Discontinuation report RAN-NABILONE
Report ID | 50989 |
Drug Identification Number | 02358077 |
Brand name | RAN-NABILONE |
Common or Proper name | RAN-NABILONE |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NABILONE |
Strength(s) | 0.25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A04AD |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-05-31 |
Actual discontinuation date | 2018-05-31 |
Remaining supply date | 2018-05-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2018-06-01 | English | Compare |
v2 | 2018-05-31 | French | Compare |
v1 | 2018-05-31 | English | Compare |
Showing 1 to 3 of 3